AllSight
Companies · RDNT · Services-Medical Laboratories

RadNet, Inc. (RDNT)

RadNet, Inc. (RDNT) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

RadNet, Inc. (RDNT) stock — financials & valuation

Key numbers for RadNet, Inc. (RDNT): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 35/100 — a percentile rank of RadNet, Inc.’s fundamentals against Services peers, weakest on management. A quality ranking, not a price prediction.

Market cap$5.3B
P / S2.4×
EV / EBITDA22.4×
Gross margin59.4%
Operating margin3.6%
Net margin0.8%
Return on equity-1.9%
ROIC2.3%
Revenue growth18.9%
Debt / equity1.2×
Dividend yield0.0%

Is RadNet, Inc. overvalued? P/S looks fair vs its 5-year range; EV/EBITDA looks fair vs its 5-year range; P/B looks overvalued vs its 5-year range.

Independent of the events above — derived from RadNet, Inc.’s own financial statements and shown as context, never as advice.

Aug 14, 2026Share issuance
RadNet’s latest filing is less a surprise than a paperwork-driven share overhang
Aug 10, 2026
Record growth beats expectations, but adjusted EPS declines and AI investment weighs
Related companies in Services-Medical Laboratories
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact